Pharmacokinetic-Pharmacodynamic and Response Sensitization Modeling of the Intraocular Pressure-Lowering Effect of the EP4 Agonist 5- -5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270)